ViewRay, Inc. (NASDAQ:VRAY) is scheduled to issue its quarterly earnings data after the market closes on Monday, November 13th. Analysts expect the company to announce earnings of ($0.12) per share for the quarter.

Shares of ViewRay, Inc. (NASDAQ:VRAY) opened at $8.51 on Friday. ViewRay, Inc. has a 12-month low of $2.67 and a 12-month high of $10.39. The company has a quick ratio of 1.45, a current ratio of 1.73 and a debt-to-equity ratio of -2.62.

A number of institutional investors have recently made changes to their positions in the business. State Street Corp increased its stake in shares of ViewRay by 631.7% during the second quarter. State Street Corp now owns 395,418 shares of the company’s stock valued at $2,555,000 after buying an additional 341,376 shares during the period. California State Teachers Retirement System increased its stake in shares of ViewRay by 280.5% during the second quarter. California State Teachers Retirement System now owns 51,819 shares of the company’s stock valued at $335,000 after buying an additional 38,200 shares during the period. Finally, The Manufacturers Life Insurance Company purchased a new position in shares of ViewRay during the second quarter valued at approximately $159,000. 53.64% of the stock is currently owned by institutional investors and hedge funds.

VRAY has been the subject of a number of recent research reports. Mizuho initiated coverage on ViewRay in a research report on Wednesday, September 6th. They issued a “buy” rating and a $12.00 target price for the company. Aegis reaffirmed a “buy” rating and issued a $11.00 price target on shares of ViewRay in a research note on Saturday, July 22nd. Finally, ValuEngine cut ViewRay from a “hold” rating to a “sell” rating in a research note on Friday, September 22nd. One equities research analyst has rated the stock with a sell rating and five have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $10.00.

COPYRIGHT VIOLATION NOTICE: “ViewRay, Inc. (VRAY) Set to Announce Quarterly Earnings on Monday” was originally reported by Watch List News and is the property of of Watch List News. If you are viewing this article on another publication, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The legal version of this article can be viewed at

About ViewRay

ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.

Earnings History for ViewRay (NASDAQ:VRAY)

Receive News & Ratings for ViewRay Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ViewRay Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.